Competition

  • January 27, 2026

    Medtronic Rival's VP Says Docs Praised Device But Didn't Buy

    A vice president in charge of sales at Applied Medical testified Tuesday in a California federal trial over his company's antitrust claims against Medtronic, and said the overwhelmingly positive feedback Applied received from surgeons who used its advanced bipolar devices often didn't result in sales. 

  • February 12, 2026

    Law360 Seeks Members For Its 2026 Editorial Boards

    Law360 is looking for avid readers of our publications to serve as members of our 2026 editorial advisory boards.

  • January 27, 2026

    NCAA Warns Of Broad Impacts In WVU Players' Eligibility Row

    If a West Virginia federal court's decision to give four football players another year of eligibility is left standing, scores of student-athletes will be emboldened to use last-minute litigation to skirt National Collegiate Athletic Association rules and secure more playing time, the NCAA's counsel told the Fourth Circuit on Tuesday.

  • January 27, 2026

    Investors Say Teva Can't Get Early Win In Price-Fixing Suit

    Investors guided by Highfields Capital told a Connecticut federal court that Teva Pharmaceuticals can't escape their claims that its alleged collusion with other drugmakers to artificially inflate the price of generic drugs also inflated stock prices, reasoning that Teva executives falsely attributed the company's performance to factors other than the alleged price-fixing.

  • January 27, 2026

    Adhesive Cos. Push Back On FTC Merger Concerns

    The makers of Loctite and Liquid Nails told a New York federal court that the Federal Trade Commission will be unable to show their planned $725 million merger will hurt competition for construction adhesives.

  • January 27, 2026

    Apple Accused Of Stealing Webcam Functionality For IPhones

    Apple was sued Tuesday by a company claiming it was induced into developing technology allowing for high-fidelity imaging in a smartphone that Apple then stole for use in iPhones.

  • January 27, 2026

    Mylan's Sanofi Insulin Suit Mostly Survives Dismissal Bid

    A Pennsylvania federal judge Tuesday largely refused to dismiss Mylan Pharmaceuticals' antitrust lawsuit accusing Sanofi of unlawfully maintaining a monopoly in the market for injectable insulin glargine.

  • January 27, 2026

    AGs' HPE-Juniper Hold Too Broad, Too Late, Judge Says

    A California federal judge explained his reasoning for refusing to block further integration between Hewlett Packard Enterprise and Juniper Networks, while Democratic attorneys general challenge the Justice Department's controversial settlement permitting the merger.

  • January 27, 2026

    Colo. Atty Says Former Mentee Poached Clients

    A Colorado attorney told a state court that a former associate he mentored for several years secretly solicited firm clients, misused confidential information and set up a competing practice while still employed.

  • January 27, 2026

    Homebuyers Say Rocket Mortgage Illegally Inflated Prices

    A proposed class of homebuyers accused Rocket Companies Inc. and its subsidiaries in Michigan federal court of illegally hiking home prices by sending business leads to real estate agents who pushed clients to use Rocket's "disadvantageous" financing services for purchases.

  • January 27, 2026

    EU Advances Brookfield, GIC's Australian Storage REIT Buy

    European regulators on Tuesday signed off on a proposed $2.6 billion buyout of Australian self-storage company National Storage REIT by Brookfield Asset Management and GIC, in a deal advised by Ashurst LLP and Clayton Utz.

  • January 27, 2026

    NRG, LS Power's $12B Natural Gas Deal Clears DOJ Scrutiny

    The U.S. Department of Justice has cleared NRG Energy Inc.'s $12 billion acquisition of 18 natural gas-fired power plants from LS Power in a cash-and-stock deal guided by White & Case LLP, Milbank LLP and Willkie Farr & Gallagher LLP.

  • January 27, 2026

    CMA Seeks To Appeal Re-Do Of £70M Pfizer, Flynn Drug Fines

    The Competition and Markets Authority sought permission from the Court of Appeal on Tuesday to challenge a decision that criticized and revised the £70 million ($96 million) in fines it issued to Pfizer and Flynn Pharma for excessive pricing.

  • January 27, 2026

    Poultry Cos. Told To Stay Separate Amid UK Antitrust Probe

    Britain's antitrust enforcer told Société LDC SA of France and Gressingham Foods, a breeder of ducks in England, on Tuesday not to integrate their poultry businesses as it carries out an investigation into the deal, which was completed in December.

  • January 26, 2026

    Mich. AG's Antitrust Suit Charts New Path For Climate Torts

    Michigan Attorney General Dana Nessel's antitrust lawsuit against fossil fuel companies opens a new front in climate change tort litigation, and is a riposte to red states using antitrust law to target pro-climate actions by companies.

  • January 26, 2026

    Senate Antitrust Chair Flags Concerns In Netflix-Warner Deal

    Netflix's proposed $82.7 billion purchase of Warner Bros. Discovery's studios and HBO streaming businesses risks being a "killer non-acquisition," Sen. Mike Lee has reportedly told the media giants' chief executives, expressing concern that a likely lengthy merger review could leave Warner Bros. in a weakened state.

  • January 26, 2026

    Justices Urged To Keep Baseball's Antitrust Shield In Play

    Puerto Rico's professional baseball league on Monday urged the U.S. Supreme Court not to disturb the sport's century-old exemption from antitrust law, arguing that the justices have rejected similar challenges to the shield time and time again.

  • January 26, 2026

    Southern Glazer's Wants To Compare FTC Case To Kroger

    Southern Glazer's Wine and Spirits LLC urged a California federal judge Friday to give it key material from the Federal Trade Commission's successful challenge to the Kroger-Albertsons merger, sparring with the FTC on arguments that the agency is contradicting itself in a price discrimination lawsuit.

  • January 26, 2026

    Generics Makers Fight Cert. In Cholesterol Drug Pricing MDL

    Generic-drug makers sought to defeat a bid to certify proposed classes comprising thousands of pharmacies that indirectly purchased and resold generics at the center of sprawling price-fixing litigation, telling a Pennsylvania federal court Monday that certification would result in an "unmanageable trial."

  • January 26, 2026

    Truck Makers Say Calif. Delaying 'Clean Trucks Pact' Fight

    Heavy-duty truck manufacturers on Monday accused California officials of trying to delay litigation over a 2023 agreement that would saddle manufacturers with stringent state emissions standards and stiff penalties for noncompliance in the coming years.

  • January 26, 2026

    Fubo Subscribers Defend Streaming Rate Suit Against Disney

    A proposed class of Fubo subscribers is opposing a bid from Disney to force them to arbitrate their claims in an antitrust case alleging streaming services pay inflated rates to carry ESPN and other sports channels.

  • January 26, 2026

    Google Targets Publishers' Ad Tech Claims

    Google asked a New York federal judge to cut out a wide swath of antitrust claims from multidistrict litigation targeting its advertising placement technology dominance, assailing in separate briefs allegations from a class of website publishers and from the Daily Mail and Gannett.

  • January 26, 2026

    9th Circ. Pauses Discovery Order In UFC Wage Suits

    A Ninth Circuit panel temporarily paused a Nevada federal court's discovery order in wage suppression lawsuits against UFC after the mixed martial arts organization said the order violated attorney-client privilege and the First Amendment.

  • January 26, 2026

    Amex Seeks First Approval Of $17M Antisteering Settlement

    American Express Co. has asked a New York federal judge to grant the first green light to a $17.5 million settlement reached with consumers who claimed the credit card company's so-called antisteering rules caused non-Amex cardholders to pay higher charges, after a New York federal jury ordered Amex to pay $12 million to one class of consumers.

  • January 26, 2026

    Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics

    A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for the GLP-1 drug Victoza.

Expert Analysis

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • A Changing Playbook For Fighting Records Requests In Del.

    Author Photo

    The Delaware Supreme Court's recent decision in Wong v. Amazon, reversing the denial of an inspection demand brought by a stockholder, serves as a stark warning to corporations challenging books and records requests, making clear that companies cannot defeat such demands solely by attacking the scope of their stated purpose, say attorneys at Duane Morris.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • FTC, CoStar Cases Against Zillow May Have Broad Impact

    Author Photo

    Zillow's partnerships with Redfin and Realtor.com have recently triggered dual fronts of legal scrutiny — an antitrust inquiry from the Federal Trade Commission and a mass copyright infringement suit from CoStar — raising complex questions that reach beyond real estate, says Shubha Ghosh at Syracuse University College of Law.

  • How 2nd Circ. Cannabis Ruling Upends NY Licensing

    Author Photo

    A recent Second Circuit decision in Variscite NY Four v. New York, holding that New York's extra-priority cannabis licensing preference for applicants with in-state marijuana convictions violates the dormant commerce clause, underscores that state-legal cannabis markets remain subject to the same constitutional constraints as other economic markets, say attorneys at Harris Beach.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • A Change In Big Pharma Response To FTC Delisting Warnings

    Author Photo

    While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.

  • 9th Circ. Finding That NFTs Are Goods Will Change TM Law

    Author Photo

    The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Lessons From Liberty Mutual FCPA Declination

    Author Photo

    Liberty Mutual’s recent Foreign Corrupt Practices Act resolution with the U.S. Department of Justice signals that the Trump administration is once again considering such declinations after an enforcement pause, offering some assurances for companies regarding the benefits of voluntary self-disclosure, say attorneys at Paul Weiss.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • FTC Focus: When Green Goals And Antitrust Law Collide

    Author Photo

    A recently concluded Federal Trade Commission investigation has turned an emissions deal involving major U.S. heavy-duty truck manufacturers that was brokered by the California Air Resources Board into a cautionary tale about the potential for environmental agreements to run afoul of competition rules, say attorneys at Proskauer.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.